期刊文献+

86例复治涂阳肺结核患者的耐药分析 被引量:7

Analysis of drug resistance among 86 patients with retreated pulmonary tuberculosis
原文传递
导出
摘要 目的探讨复治涂阳肺结核患者对抗结核药物的耐药特点。方法回顾性分析86例复治涂阳肺结核患者的单耐药、多耐药及耐多药的情况及治疗转阴率和不良反应。结果所有患者中,任何形式耐药占100%,多耐药占91.9%,耐多药占65.1%,一线药物耐药顺位为H>R>S>E,二线药物以对左氧氟沙星耐药的比例最高,占37.21%;3个月后痰菌转阴率仅为60.46%,复治病例中耐药比例最高的人群为40~60岁的中老年人,占68.96%;不良反应主要为过敏反应(54.65%)和肝功能异常(8.14%)。结论复治涂阳的肺结核耐药率高,且以中老年人为主,应当重视结核患者耐药性的检测及用药的规律性、足量性。 Objective To investigate the features of drug resistance in the patients with retreated pulmonary tuberculosis. Methods Single drug resistance, Poly-drug resistance, and multidrug resistance, treatment rate and adverse reactions in 86 patients were analyzed retrospectively. Results 100% patients showed resistance to any drug. 91.9% patients were poly-drug resistance and 65.1% patients were multidrug resistant. The sequence of the first-line anti-tuberculosis drug usage was HR SE. Levofloxacin had highest resistance (37.21%) in the second line drugs. The negative conversion rate of phlegm germ was 60.46% after treatment for 3 months. The 40~60 year old patients had highest rate of resistance to drugs (68.96%). The mainly adverse reactions were allergy (54.65%) and abnormal liver function (8.14%). Conclusion The patients with retreated pulmonary tuberculosis had higher rate of drug resistance, especially the old patients. We should pay more attention to TB culture and drug sensitivity test, and choose treatment according to the test results.
出处 《热带医学杂志》 CAS 2012年第12期1485-1487,共3页 Journal of Tropical Medicine
关键词 复治肺结核 药物耐受 抗结核药 retreated tuberculosis drug resistance anti-tuberculosis
  • 相关文献

参考文献8

二级参考文献26

共引文献84

同被引文献58

  • 1无.初治涂阴活动性肺结核病人免费治疗管理指南(试行)[J].中华结核和呼吸杂志,2005,28(10):667-669. 被引量:64
  • 2中华医学会.临床诊疗手册(结核病分册)[M].北京:人民出版社,2005:80.
  • 3戴自英.实用内科学[M].北京:人民卫生出版社,1992.241.
  • 4中国防痨协会基础专业委员会.结核病诊断实验室检验规程[M].北京:中国教育出版社,2006.13-16.
  • 5Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans[J]. Clin Infect Dis,2005, 41(5) :654-659.
  • 6卫生部疾病控制预防控制局,卫生部医政司,中国疾病预防控制中心.中国结核病防治规划实施工作指南[M].北京:中国协和医科大学出版社,2008:52-53.
  • 7Correia JW, Freitas MV, Queiroz JA. Interleukin-6 blood leve|s in sensitive and multiresistant tuberculosis [ J ]. Infection, 2009, 37 (2) :138 - 141.
  • 8Cozmei C,Constantinescu D,Carasevici E,et a1.Thl and Th2 cytokine response in patients with pulmonary tuberculosis and health care workers occupationally exposed to M.tuberculosis[J].Rev Med Chir Soc Med Nat Iasi,2007,111(3):702-709.
  • 9Correia JW,Freitas MV,Queiroz JA.Interleukin-6 bloed levels in sensitive and muhiresistant tuberculosis[J].Infection,2009,37(2):138-141.
  • 10Eto M,Koga H,Noma H,et al.Importance of urinary interleukin-18 in intravesical immunotherapy with bacillus calmetteguerin for superficial bladder tumors[J].Urol Int Urol,2005,75(2):114-118.

引证文献7

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部